tetraethylammonium has been researched along with Autoimmune Diabetes in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troncoso Brindeiro, CM | 1 |
| Fallet, RW | 1 |
| Lane, PH | 1 |
| Carmines, PK | 1 |
1 other study available for tetraethylammonium and Autoimmune Diabetes
| Article | Year |
|---|---|
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.
Topics: 4-Aminopyridine; Animals; Apamin; Arterioles; Bee Venoms; Diabetes Mellitus, Experimental; Diabetes | 2008 |